Question 1

What are the most cited papers from Visca (United States)?

Accepted Answer

The most cited paper from Visca (United States) is "Long-Term Versus Short-Term Clopidogrel Therapy in Patients Undergoing Coronary Stenting (from the Randomized Argentine Clopidogrel Stent [RACS] Trial)" (Víctor Bernardi, Jorge Szarfer, Gabriel Summay et al., 2006), with 31 citations. Next come "Prognostic impact of second primary tumors in head and neck cancer" (21) and "Unstable Thoracolumbar Injuries: Factors Affecting the Decision for Short-Segment vs Long-Segment Posterior Fixation" (11).

Question 2

Which research topics does Visca (United States) publish most on?

Accepted Answer

By volume in 2022-now: PARP inhibition in cancer therapy, Chronic Obstructive Pulmonary Disease (COPD) Research, Pleural and Pulmonary Diseases and Health and Lifestyle Studies.

Question 3

Which fields of science does Visca (United States) work in?

Accepted Answer

In all years, 96% of research at Visca (United States) is in Health Sciences, 3% in Life Sciences. Its largest fields are Medicine (92%), Health Professions (4%), Biochemistry, Genetics and Molecular Biology (2%). It does 2.0× the world's share of Health Sciences.

Question 4

Is Visca (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 139% higher than in 2018-2021.